Skip to main content
Caplight Logo









binx health

binx health

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://mybinxhealth.com/

Last Round

Series F

Apr 2, 2024

Total Funding Raised

$293.43M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

binx health is a health technology company that develops point-of-care molecular diagnostic platforms for the rapid detection of infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Patient Engagement

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care testingmolecular diagnosticsat-home testingPOC diagnosticsrapid testingdiagnostic platforminfectious disease testingsexual health testingdirect-to-consumer diagnosticsDTC testingclinical diagnosticshealth techdiagnostic hardwaretesting cartridgeslab-at-home

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

binx health Comparables

Compare binx health with similar companies based on industry and business-model similarity.

binx health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantuMDx
81%
Visby Medical
80%
Novel Microdevices
79%

binx health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FApr 2, 2024
Series EMay 27, 2021
GrantAug 17, 2017
Series DJan 23, 2017
GrantMar 15, 2016
Grant
Jun 11, 2015

Key People

Founding team and executive leadership

Jack Crowley

Chief Financial Officer

Executive Team

Timothy Stewart

Chief Financial Officer

Executive Team

Anna Dixon

Chief Operating Officer

Executive Team

binx health Investors

Notable investors and investment history

binx health investors
InvestorRounds
Asabys PartnersSeries E
Innovate UKGrant
Technology Venture PartnersSeries D, Series C
Alta Life SciencesSeries E
EQT Life SciencesSeries F, Series C, Series B Extension, Series E, Series B, Series D
UK governmentGrant
HildredSeries E, Series F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2026

    FDA-cleared and CLIA-Waived point-of-care platform for STI testing.

  • Apr 2, 2024

    $65M round led by Hildred

binx health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

binx health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about binx health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range94
Year Founded2005
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?